232 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
any commitment that would conflict or interfere in any material respect with the Company’s obligations to the Investors under the Transaction
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
, including an irrevocable commitment by a broker to pay over such amount from a sale of the shares issuable under an option, the delivery
8-K
EX-99.2
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
converted into shares of common stock at the applicable conversion ratio then in effect upon either (i) the closing of a firm-commitment underwritten
8-K
EX-10.10
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
commitment by a broker to pay over such amount from a sale of the shares of Common Stock issuable under an Option, the delivery of previously owned shares
8-K
EX-3.6
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
commitment or assurance to, any person or entity: (1) as to how the person, if elected as a director, will act or vote on any issue or question
8-K
EX-99.3
20w2m9hsluzpm8
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-14.1
sstn33 kvim
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
425
EX-10.1
fn8ohiz
15 Aug 24
Business combination disclosure
4:17pm
8-K
EX-10.1
dd10n rbmty
15 Aug 24
Entry into a Material Definitive Agreement
4:15pm
424B3
hfj vz92ohq
1 Aug 24
Prospectus supplement
4:10pm
425
EX-10.2
j6djq 8hyx8ck
9 Jul 24
Business combination disclosure
5:04pm
8-K
EX-10.2
h4c0ax6xfdu
9 Jul 24
Entry into a Material Definitive Agreement
5:01pm